Join
Live feed
·
INSIDERFilingvia Quantisnow
POINT Biopharma Global Inc. logo

SEC Form 4: Lubner David Charles bought $24,660 worth of shares (3,600 units at $6.85)

ByQuantisnow·Wall Street's wire, on your screen.
PNT· POINT Biopharma Global Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PNT (POINT Biopharma Global Inc.) and more on Quantisnow.